Search by Drug Name or NDC

    NDC 37000-0448-12 Vicks 10; 200 mg/15mL; mg/15mL Details

    Vicks 10; 200 mg/15mL; mg/15mL

    Vicks is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by The Procter & Gamble Manufacturing Company. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 37000-0448
    Product ID 37000-448_eac4e3bf-2155-e120-e053-2a95a90affe9
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Vicks
    Proprietary Name Suffix Formula 44 Cough and Chest Congestion
    Non-Proprietary Name Dextromethorphan Hydrobromide, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 10; 200
    Active Ingredient Units mg/15mL; mg/15mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name The Procter & Gamble Manufacturing Company
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number M012
    Listing Certified Through 2023-12-31

    Package

    NDC 37000-0448-12 (37000044812)

    NDC Package Code 37000-448-12
    Billing NDC 37000044812
    Package 354 mL in 1 BOTTLE, PLASTIC (37000-448-12)
    Marketing Start Date 2017-07-11
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 4e77a097-eb35-4d14-e054-00144ff88e88 Details

    Revised: 10/2022